[Effects of specific small interfering RNA on Smoothened expression and LoVo cell proliferation and apoptosis]

Area of Science:

• Molecular Biology
• Cancer Research
• Genetics

Background:

• Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide.
• The Smoothened (Smo) gene plays a critical role in the Hedgehog signaling pathway, which is implicated in CRC development and progression.
• Targeting key genes like Smo presents a potential therapeutic avenue for CRC treatment.

Purpose of the Study:

• To investigate the efficacy of specific small interfering RNA (siRNA) in downregulating Smo gene expression in LoVo colorectal cancer cells.
• To evaluate the impact of Smo gene silencing on the proliferation and apoptosis rates of LoVo cells.

Main Methods:

• LoVo cells were transfected with three distinct siRNAs targeting the Smo gene using cationic liposomes.
• Semi-quantitative RT-PCR was employed to measure Smo mRNA levels 48 hours post-transfection.
• Flow cytometry and MTT assays were utilized to assess cellular proliferation and apoptosis.

Main Results:

• One siRNA (siRNA-1) significantly reduced Smo mRNA expression by approximately 63.56% in LoVo cells 48 hours after transfection.
• Smo siRNA-1 transfection led to a significant decrease in LoVo cell proliferation compared to control groups.
• A notable increase in the apoptosis rate was observed in cells transfected with Smo siRNA-1.

Conclusions:

• Specific siRNA targeting the Smo gene can effectively inhibit its expression in colorectal cancer cells.
• Downregulation of Smo gene expression via siRNA demonstrates potential in suppressing cancer cell proliferation and inducing apoptosis.
• These findings suggest that Smo-targeting siRNA could be a promising therapeutic agent for colorectal cancer.